Published in Support Care Cancer on December 14, 2013
Rates and risks for late referral to hospice in patients with primary malignant brain tumors. Neuro Oncol (2015) 0.85
Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs. Support Care Cancer (2014) 0.77
Screening for Psychological Distress in Adult Primary Brain Tumor Patients and Caregivers: Considerations for Cancer Care Coordination. Front Oncol (2015) 0.76
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study. Support Care Cancer (2015) 0.76
Advance Care Planning in Glioblastoma Patients. Cancers (Basel) (2016) 0.75
End-of-life care in patients with primary malignant brain tumors: early is better. Neuro Oncol (2015) 0.75
Advance Care Planning in Patients with Primary Malignant Brain Tumors: A Systematic Review. Front Oncol (2016) 0.75
Do carer's levels of unmet needs change over time when caring for patients diagnosed with high-grade glioma and how are these needs correlated with distress? Support Care Cancer (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol (2012) 5.71
End-of-life decision-making in six European countries: descriptive study. Lancet (2003) 5.16
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol (2012) 4.70
End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med (2007) 4.21
Euthanasia and other end of life decisions and care provided in final three months of life: nationwide retrospective study in Belgium. BMJ (2009) 3.99
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91
Graph theoretical analysis of complex networks in the brain. Nonlinear Biomed Phys (2007) 3.20
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin Cancer Res (2010) 3.13
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood (2008) 2.97
Chemotherapy-induced neuropathy. J Peripher Nerv Syst (2008) 2.97
Training of future interventional neuroradiologists: the European approach. Stroke (2012) 2.90
The role of nurses in physician-assisted deaths in Belgium. CMAJ (2010) 2.90
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. J Clin Oncol (2009) 2.65
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol (2003) 2.63
Involvement of nurses in physician-assisted dying. J Adv Nurs (2004) 2.57
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol (2006) 2.49
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin Cancer Res (2005) 2.46
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res (2006) 2.44
Establishing specialized health services for professional consultation in euthanasia: experiences in the Netherlands and Belgium. BMC Health Serv Res (2009) 2.40
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol (2009) 2.35
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs (2003) 2.35
Prediction of venous thromboembolism in cancer patients. Blood (2010) 2.31
Euthanasia and other end-of-life decisions: a mortality follow-back study in Belgium. BMC Public Health (2009) 2.25
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol (2006) 2.11
Similarities and differences between continuous sedation until death and euthanasia - professional caregivers' attitudes and experiences: a focus group study. Palliat Med (2012) 2.09
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma. Neurology (2014) 2.02
Physician-assisted deaths under the euthanasia law in Belgium: a population-based survey. CMAJ (2010) 2.01
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol (2003) 2.00
The practice of continuous sedation until death in nursing homes in Flanders, Belgium: a nationwide study. J Am Geriatr Soc (2014) 1.99
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. J Clin Oncol (2009) 1.99
The use of drugs with a life-shortening effect in end-of-life care in neonates and infants. Intensive Care Med (2005) 1.96
Recent advances in therapy for glioblastoma. Arch Neurol (2010) 1.92
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res (2006) 1.91
The medical practice of euthanasia in Belgium and The Netherlands: legal notification, control and evaluation procedures. Health Policy (2008) 1.87
Disturbed functional connectivity in brain tumour patients: evaluation by graph analysis of synchronization matrices. Clin Neurophysiol (2006) 1.82
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol (2010) 1.78
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol (2012) 1.74
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. Brain Pathol (2008) 1.74
Low-grade gliomas in adults. J Neurosurg (2011) 1.73
Pseudoprogression and pseudoresponse: challenges in brain tumor imaging. Curr Neurol Neurosci Rep (2009) 1.72
Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. J Neurosurg (2006) 1.67
The euthanasia law in Belgium and the Netherlands. Lancet (2003) 1.67
Good end-of-life care according to patients and their GPs. Br J Gen Pract (2006) 1.66
Hospitalisations at the end of life: using a sentinel surveillance network to study hospital use and associated patient, disease and healthcare factors. BMC Health Serv Res (2007) 1.61
Continuous deep sedation until death in Belgium: a nationwide survey. Arch Intern Med (2010) 1.60
The role of general practitioners in continuity of care at the end of life: a qualitative study of terminally ill patients and their next of kin. Palliat Med (2007) 1.59
The molecular mechanism underlying Roberts syndrome involves loss of ESCO2 acetyltransferase activity. Hum Mol Genet (2008) 1.58
Which patients with cancer die at home? A study of six European countries using death certificate data. J Clin Oncol (2010) 1.58
General practitioners' report of continuous deep sedation until death for patients dying at home: a descriptive study from Belgium. Eur J Gen Pract (2010) 1.56
P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol (2005) 1.55
The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol (2006) 1.55
Do-not-resuscitate decisions in six European countries. Crit Care Med (2006) 1.54
Transitions between care settings at the end of life in belgium. JAMA (2007) 1.53
The incidence and characteristics of end-of-life decisions by GPs in Belgium. Fam Pract (2004) 1.52
Truth-telling at the end of life: a pilot study on the perspective of patients and professional caregivers. Patient Educ Couns (2008) 1.51
[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme. J Neurooncol (2007) 1.51
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial. Ann Intern Med (2016) 1.51
Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol (2010) 1.49
EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliat Med (2006) 1.49
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol (2008) 1.48
Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging (2004) 1.47
SMART syndrome: a late reversible complication after radiation therapy for brain tumours. J Neurol (2011) 1.47
Expressed wishes and incidence of euthanasia in advanced lung cancer patients. Eur Respir J (2012) 1.46
The reporting rate of euthanasia and physician-assisted suicide: a study of the trends. Med Care (2008) 1.46
Palliative care and euthanasia in countries with a law on euthanasia. Palliat Med (2003) 1.46
The use of palliative care services associated with better dying circumstances. Results from an epidemiological population-based study in the brussels metropolitan region. J Pain Symptom Manage (2011) 1.45
Place of death of older persons with dementia. A study in five European countries. J Am Geriatr Soc (2010) 1.44
Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study. Anticancer Drugs (2014) 1.43
[Improved end-of-life care for patients with dementia: greater family satisfaction and possibly greater end-of-life comfort]. Ned Tijdschr Geneeskd (2013) 1.43
End-of-life decision making in neonates and infants: comparison of The Netherlands and Belgium (Flanders). Acta Paediatr (2007) 1.42
Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma. Nucl Med Commun (2007) 1.41
Neuromuscular electrical stimulation for a patient with metastatic lung cancer--a case report. Support Care Cancer (2006) 1.41
Secondary coproporphyrinuria in a patient with the full clinical picture of a hereditary acute hepatic porphyria. A misleading clinical and biochemical course. J Neurol (2002) 1.40
Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics (2009) 1.40
GPs' awareness of patients' preference for place of death. Br J Gen Pract (2009) 1.39
Continuous deep sedation: physicians' experiences in six European countries. J Pain Symptom Manage (2006) 1.39
Dying at home or in an institution using death certificates to explore the factors associated with place of death. Health Policy (2005) 1.39
3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys (2004) 1.38
How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol (2006) 1.38
Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). Oncol Rep (2002) 1.36
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer (2009) 1.35
Reporting of euthanasia in medical practice in Flanders, Belgium: cross sectional analysis of reported and unreported cases. BMJ (2010) 1.34
Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2005) 1.33
Using death certificate data to study place of death in 9 European countries: opportunities and weaknesses. BMC Public Health (2007) 1.31